The comparable abundances (~ 74% of total tumour) of the CYSLTR2 mutation, gain of 8q and losses of 1p and 16q suggest that these alterations are clonally present in this sample and occurred during an early developmental phase. Here, CYSLTR2 is linked to neoplasm.